Cardiol Therapeutics (CRDL) Receivables - Net: 2021-2022
Historic Receivables - Net for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to -$67,764.
- Cardiol Therapeutics' Receivables - Net fell 29.64% to -$67,764 in Q3 2022 from the same period last year, while for Sep 2022 it was -$67,764, marking a year-over-year decrease of 29.64%. This contributed to the annual value of $52,457 for FY2021, which is N/A change from last year.
- Per Cardiol Therapeutics' latest filing, its Receivables - Net stood at -$67,764 for Q3 2022, which was down 44.86% from -$46,779 recorded in Q2 2022.
- In the past 5 years, Cardiol Therapeutics' Receivables - Net registered a high of $52,153 during Q4 2021, and its lowest value of -$87,642 during Q2 2021.
- Over the past 2 years, Cardiol Therapeutics' median Receivables - Net value was -$46,779 (recorded in 2022), while the average stood at -$35,816.
- Within the past 5 years, the most significant YoY rise in Cardiol Therapeutics' Receivables - Net was 46.63% (2022), while the steepest drop was 29.64% (2022).
- Cardiol Therapeutics' Receivables - Net (Quarterly) stood at $52,153 in 2021, then fell by 29.64% to -$67,764 in 2022.
- Its last three reported values are -$67,764 in Q3 2022, -$46,779 for Q2 2022, and -$17,702 during Q1 2022.